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ABSTRA CT 
S kin fro m 6 pa ti en ts wi th scleroderma , 3 wi t h scl eredema a nd 5 norma l con t rols were 
s ubjected to qua li tative a nd qua n t itative a na lys is of glycosa minoglycans. G lycosami-
n oglyca ns were iden t ified by cety lpy ridinium chl oride- a lt fractionation a nd by cellulose 
acetate electrophoresis. Our data suggest t hat in scl eredema t he re may b e a n increase in 
hya luroni c ac id whil e the con cen t rat ion of dermata n sulfate is norma l. All scl eroderma 
s pec imen s revea led a ma rked in crease in dermata n sul fate. 
" S cl e rod erm a a nd sc le redema a re connec tive 
t issu e disord ers cha racteri zed by marked indu ra-
t ion of t he s kin . Systemi c scleroderma us ua lly 
affects th e face, ha nds and fo rearms; loca li zed 
scler o d e rma has p redilection fo r t he t runk a nd 
extrem it ies whil e sc lerede ma most frequently a f-
fects t he bac k of t he n ec k and the back. The in-
, durati on of th e s kin resul ts from a ma rked in-
crease in collagen co n ten t due to the replacem en t 
of t h e s ubcutaneous t issue by n ewly syn t hesized 
con n ective t issue (1, 2). Another feature, common 
to b oth disord ers, is the high in cidence of glucose 
intol e ra n ce a nd hy perinsulinis m (2, 3). On histo-
logic grounds, there a re s ignificant di He rences 
_between the collagen of scleredema and sclero-
derma. In sc lerode rma, t he coll agen is either 
cornpact or hyalini zed whil e in scl erede ma it 
a ppears as t hic k bundles sepa rated by la rge, clear 
inter fi b rous spaces. The purpose of thi s investiga-
t ion was to perfo rm quantitative a nd qua li tat ive 
ana lysis of de rma l glycosa minoglyca ns (GAG) in 
sclered e ma a nd scleroderma. 
MATERIALS AND METHODS 
Skin biopsies · were ta ken from six cases of sclero-
der ma and three of scleredema. For clinical details see 
'fab le I. ·controls consisted of five normal skins ta ken 
from t he medial incision of fresh autopsy ma terial (ages: 
15, 41, 43, 65 and 67 years). T he specimens fo r histology 
wer e fixed in 10% buffered formalin and sta ined with 
hematoxylin and eosin , Gomori 's and Mallory's tri-
ch rome, periodic ac id SchilT, aldehyde fuchsin and Al -
cian blue, pH 2.5. 
The specimens for chemical analys is were defatted 
for 3 d ays in acetone-ether, cut in to small pieces, about 
1 rom 3 and dri ed in a desiccator. The average dry 
weigh t of the specimens was as follows: scleroderma 63 
mg; s cleredema 92 mg and cont rols 75 mg. Fract iona-
tion o f glycosa minoglycans was performed at a micro 
scale a dapted from the method of Schiller et al. (4) . The 
· basic steps were as follows: a) di gestion for 24 hours at 
60° C wi th papain, two t imes crystallized suspension 
(Sigma) 3 mg/g skin in 0.1 M acetate buffer, pH 5.5 
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containing 0.005 cysteine- HCl and 0.005 disod ium ver-
senate; b) treatment with 0.5 N sodium hydroxide for 4 
hours; c) dialys is against ta p water un t il pH 8.5-8.9 was 
achieved; d) digestion with try psin, twice crysta lli zed 
(Mann Research Laborato ri es) , 1.0 mg/g skin in 0. 1 M 
Na 2 HP O,, pH 8.0 for 3 days at 37° C; e) precipitation 
of proteins by addin g t richloroacetic acid to a fi nal con-
cent ration of 10%; t) dialysis against distilled water for 
3 days; g) preci pi tat ion of glycosaminoglyca ns with 0.03 
M NaC l-0.1% cetylpyrid inium chloride (CPC) ; h) ex-
traction of the prec ipitate successively with 0.03 M 
aC l-0.1% CPC (glycoproteins): 0.4 M NaCl-0.1% CPC 
(hyalu ronic acid); 1.2 M NaCl-0. 1% CPC (dermatan sul-
fate) and 2.1 M NaCI. Uroni c acids were estimated by 
the carbazole reaction of Bitte r and Muir (5) using glu-
curonolactone as a standard. About 90% of the tota l 
GAG were found in the 0.4 an d 1.2 M aCl extracts. 
The glycosam inoglyca ns of each extract were a lso 
studied by cellulose acetate electrophoresis. The buffe r 
consisted of equal parts of 0.1 M calcium acetate-0. 1 M 
copper acetate, pH 3.6 (6). The sa mpl es were run in a 
Gelman horizontal chamber at 1.5 Mamp per strip for 2 
hours. The stri ps (Sepraphore 2.5cm x 17cm) were 
stained fo r 8 minutes in 1% Alcian blue-S G X in 
ethanol-acetate buffer (1: 1, v/v) pH 5.8, ionic strength 
0.05 (7) . Desta ining was ca rried out with 5% acet ic acid 
in 10% ethanol for 10 minutes. The above system sepa-
rates hyaluronic, dermatan sulfate and chondroit in sul -
fate (see Figure). However, heparin revealed an electro-
phoretic mobili ty similar to dermatan sulfate. In order to 
separate these two GAG, the buffer proposed by Gore 
et al. (8) was ut ili zed. T his buffer consisted of acetic 
acid : water: pyridine (100: 695:5, v/v) pH 3.6. T he puri-
fied GAG standards, kindly supplied by Dr. M. B. 
Mathews, consisted of hya luronic acid, chondroit in , der-
matan sulfate, chondroit in sulfate A and C, and hepann . 
RESULTS 
Histology. In the sclerod erma s pec imens, t he 
d e rmis cons isted of t hi c k co llage n bundles, 
t ightly packed due to reduction or disa ppea ra nce 
of t he interfascicular s paces . The collagen in the 
dermis stained norma lly with the t ri ch ro mes. T he 
lower levels corres ponding to the subcuta neous 
t issue a rea revealed hyalini zed connective t issue 
and the collagen stained very light with the t ri -
chrom es . An increase in Alcian blue pos itive ma-
teria l was noted wi t hin the hyalini zed a reas in 4 
cases (Case 1, 2, 4 and 5). The sclerede ma skin 
was ma rkedly increased in thickness due to the 
re place m en t of t h e s ub cuta n eous tiss ue by 
connective t issue (2). T he collagen bundles were 
thi c k but sta ined n ormally wi t h t he t ri chrom e. 
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TABLE I 
Clinical data 
Case Age Sex Duration Biopsy Clinica l pi cture Dia ~rnos i s No. site 
46 F 18 years finger Raynaud 's. Acroscleros is. Ca lcinosis Systemic scleroderma. 
cutis. Ulcers. Gangrene. Dysphagia. 
Dyspnea. 
2 46 F 2 years forearm Raynaud 's. Acrosclerosis. Dysphagia. Systemic scleroderma. 
Dyspnea. 
3 63 M 2 years dorsum Raynaud 's. Acrosclerosis. Pulmonary Systemic scleroderma. 
hand fibrosis. Dyspnea. 
4 39 F 1 year forearm Raynaud 's. Acrosclerosis. Pulmonary Systemic scleroderma. 
!ibrosis. 
5 37 M 2 years forearm Raynaud's. Acrosclerosis. Ulcers. Systemic scleroderma. 
Pulmonary fibrosis . 
6 19 F 3 years thigh Skin induration: neck, arm, chest, Localized scleroderma. 
back and thigh. Other systems: 
normal. 
7 59 M 5 years back Skin induration: neck, back and ab- Scleredema. 
domen. Obesity. Diabetes mellitus. 
Hypertension. Coronary infarction . 
8 61 M 10 years back Skin induration: neck and back. Obe- Scleredema. 
sity. Diabetes mellitus. Card iac 
insuffici ency. 
9 48 M 25 years back Skin induration: neck and back. Obe- Scleredema. 
sity . Diabetes mellitus. Hyperten-
sion. Angina pectoris. 
No increase in GAG was noted in the cleredema 
specimens. 
Chemistry. The results of t he fractionation of 
GAG for each individual patient is reported in 
Table II. Means, standard deviation, statistical 
analysis and percentage distribution are reported 
in Tables III and IV . 
The concentration of GAG in scleredema was 
normal in two cases and increased in the third 
one. There was an increase in hyaluronic acid in 
two cases (see Table II) while the concentration of 
dermatan sulfate was normal. 
There was a significant increase in GAG in 
scleroderma, due to an increase in dermatan sul-
fate (p < .001) . The concentration of hyaluronic 
acid was normal except for case 1 where it was 
increased. On a percentage basis there was a de-
crease in hyaluronic acid and an increase in der-
matan sulfate. 
Electrophoresis revealed hyaluronic acid in the 
0.4 M NaCl extract and dermatan sulfate in the 
1.2 M NaCl fraction . Since the yield of the 2.1 M 
NaCl extracts was too low, it was not possible to 
identify the GAG of this fraction . However, in a 
second experiment, using large amounts of skin 
from the normal controls (about 3 grams), the 
electrophoresis of the 2.1 M fraction by the Gore 
et al. (8) system, revealed a GAG with the elec-
trophoretic mobility of dermatan sulfate. Unfor-
tunately, we could not perform similar studies 
with the scleroderma and scleredema specimens 
since the amount of skin available was too smal l. 
In rat skin, the GAG present in the 2.1 M NaCl 
extract was identified as heparin (4) although 
Breen et al. (7) were not able to detect heparin in 
normal human skin. 
DISCUSSION 
T he increase in hyaluronic acid in scleredema 
is in agreement with previous hi stochemical 
studies (9, 10) . However, it is well known that this 
histologic finding is not consistent since in many 
cases no increase in GAG could be detected (2). It 
is likely that the increase in GAG may be re-
stricted to dermal areas where there is enhance-
ment in collagen synthes is. However, when the 
disease reaches a s teady stage of collagen syn-
thes is, the amount of GAG present may be no dif-
ferent from that seen in normal dermis . 
This study revealed a significant increase in 
dermatan sulfate in scleroderma skin. Braun-
Falco noted an increase in GAG during the early 
stage of scleroderma (11) . Denko and Stoughton 
(12) reported an increased uptake of 35S by sclero-
derma skin although these authors did not sug-
gest that this finding was conclusive for an in-
crease in GAG. Boas and Foley (13) mentioned an 
increase in hexosamines in the corium and subcu-
taneous tissue in scleroderma although their data 
were never published. The dermis appears to con-
tain two pools of dermatan sulfate: a) those sol-
uble in neutral salt solutions which correspond to 
the ground substance and b) those insoluble in 
sa lt solutions or presumably bound to collagen (6, 
14, 15). The increase in derma tan sulfate in scle-
roderma raises the following questions: a) does it 
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FIGURE. Electrophoresi.s of glycosaminoglycans from scleroderma. Scleredema s pecimens showed the sa me pat-
tern . (HA: Hyaluromc ac td ; DS/ dermatan sulfa te). 
TABLE II 
Fractionation of dermal glycosaminoglycans, expressed 
as p.g of uronic acid (Bi tter & Muir) /gm dry weight 
Case 0.4 M % !.2M % 2. 1M Total o. NnC I NnCI NnCI % GAG 
1 410 44 464 50 58 6 932 
2 148 20 502 70 70 10 720 
3 280 28 656 67 46 5 982 
4 236 28 520 62 78 10 834 
5 190 21 664 74 43 5 897 
6 170 23 423 56 158 21 751 
7 193 43 228 51 23 6 444 
8 280 53 225 43 23 4 528 
9 317 45 368 52 20 3 705 
take place in the ground substance, or in the frac-
tion bound to collagen or in both? b) is the in -
crease in dermata n sulfate res ponsible, at least in 
part, for the compact or hyalini zed appearance of 
the connec tive t issue? 
Electron microscopy has shown that the dermis 
in sc leroderma is bas icall y normal while the hy-
alini zed a reas corres ponding to the subcuta neous 
tissue revealed a marked increase in ground sub-
stance accompanied by immature collagen fibrils 
(1). It is likely tha t an in crease in dermata n sul-
fate ta kes place in the ground substance corre-
sponding to the areas of hya lini zation since these 
a reas a lso show an increase in GAG with the Al -
cian blue sta in. On the other hand, it is note-
worthy that in a previous study we reported a 
significa nt increase in hexosa mines in insoluble 
collagen from sclerod erma skin (16). Thus, we 
may hy pothes ize that pa rt of the increased der-
matan ulfate may a lso be linked to co llagen. 
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TABLE III 




0.4M NaC I 
238 ± 88 
264 ± 52 





538 ± 92 
274 ± 67 
205 ± 43 
Numbers in parentheses: number of cases studied. 
NSS : not s tatistically sign ificant. ' 
TABLE IV 
Percentage distribution. of dermal glycosaminoglycans 
OAM I' I. 2M I' 2. 1M p NaCI NaCI NaCI 
Scleroderma (6) 28 < .01 63 < .005 9 NSS 
Scleredema (3) 47 NSS 49 NSS 4 < .025 
Controls (5) 42 47 11 
Numbers in parentheses represent number of cases 
studied . 
NSS : not statistically sign ificant. 
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